Caris
Labcorp, University Health System Pay $388K to Resolve False Claim Allegations
The government alleges Labcorp and UHS delayed submission of orders for tests by Caris Life Sciences to enable improper billings to Medicare for those tests.
Caris Life Sciences Expands Access to Urologic Cancer Tests Through Deal With Lumea
The firms agreed to make Caris' whole-exome and whole-transcriptome sequencing tests available through Lumea's BxLink digital pathology software.
Caris Life Sciences CDx Assay Nabs FDA Approval
The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.
Caris Life Sciences, EDX Medical Ink Molecular Profiling Distribution Agreement
EDX Medical has the exclusive rights to distribute Caris' portfolio of molecular profiling services throughout the UK and four Nordic countries.
Caris Life Sciences, Juniper Biologics Expand Solid Tumor Profiling Distribution Deal
The deal expands the previous agreement, granting Juniper exclusive distribution rights throughout Africa and the Middle East.
Sep 7, 2022
May 19, 2021